These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9723434)
41. Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. Toyama Y; Murase N; Galvao FH; Sakamoto T; Nomoto M; Starzl TE; Todo S Transplant Proc; 1996 Oct; 28(5):2506-7. PubMed ID: 8907924 [No Abstract] [Full Text] [Related]
42. Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine A in organ transplantation. Padberg WM; Morgalla H; Buhr J; Hild P; Schwemmle K Transplant Proc; 1991 Feb; 23(1 Pt 1):348. PubMed ID: 1671302 [No Abstract] [Full Text] [Related]
43. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467 [No Abstract] [Full Text] [Related]
44. Immunosuppressive mechanism and immune tolerance of FK 506 in rat small bowel transplantation. Nakai T; Kawabe T; Satoh S; Kurooka K; Yasutomi M Transplant Proc; 1996 Apr; 28(2):1091-3. PubMed ID: 8623237 [No Abstract] [Full Text] [Related]
45. [Survival of skin and heart transplants in inbred rats treated with immunosuppressive agents]. Sossi G; Casseler F; Pettirossi O Minerva Stomatol; 1981; 30(6):617-20. PubMed ID: 7035863 [No Abstract] [Full Text] [Related]
46. Two new DNA synthesis inhibitors with potent immunosuppressive activity prolong allograft and xenograft survival in small and large animals. Goodman ER; Fiedor PS; Fein S; Sung RS; Athan E; Hardy MA Transplant Proc; 1996 Apr; 28(2):920-1. PubMed ID: 8623463 [No Abstract] [Full Text] [Related]
47. FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813 III. In vivo activities. Fujine K; Ueda H; Hino M; Fujii T J Antibiot (Tokyo); 2003 Feb; 56(2):68-71. PubMed ID: 12715863 [TBL] [Abstract][Full Text] [Related]
48. Effect of FK506 ointment (Protopic) on rat skin allograft model. Kim YE; Eun SC Transplant Proc; 2014 May; 46(4):1222-5. PubMed ID: 24815165 [TBL] [Abstract][Full Text] [Related]
49. Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. Platz KP; Mueller AR; Langrehr JM; Neuhaus P; Schraut WH Transplant Proc; 1996 Oct; 28(5):2523-4. PubMed ID: 8907933 [No Abstract] [Full Text] [Related]
50. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447 [No Abstract] [Full Text] [Related]
51. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat. Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424 [No Abstract] [Full Text] [Related]
52. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. Woo J; Ross CS; Milton JI; Thomson AW Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112 [No Abstract] [Full Text] [Related]
53. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. Miki T; Goller A; Rao A; Wang X; Yin WY; Tandin A; Fung JJ; Starzl TE; Valdivia LA Transplant Proc; 1998 Jun; 30(4):1091-2. PubMed ID: 9636444 [No Abstract] [Full Text] [Related]
54. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin. Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151 [No Abstract] [Full Text] [Related]
55. Prolongation of concordant xenograft survival by treatment with FTY720. Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334 [No Abstract] [Full Text] [Related]
56. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. Masri MA Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412 [No Abstract] [Full Text] [Related]
58. Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. Ishibashi M; Moutabarrik A; Kameoka H; Takano Y; Jiang H; Kokado Y; Takahara S; Sonoda T Transplant Proc; 1991 Dec; 23(6):2967-9. PubMed ID: 1721330 [No Abstract] [Full Text] [Related]
59. Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity. McAlister VC; Keshavamurthy M; Lee TD Transplant Proc; 1999; 31(1-2):1110. PubMed ID: 10083495 [No Abstract] [Full Text] [Related]
60. Effect of FK-506 on heart allograft survival in the highly sensitized recipient rats as compared with ciclosporin and 15-deoxyspergualin. Jiang H; Takahara S; Kyo M; Kokado Y; Ishibashi M; Sonoda T Eur Surg Res; 1991; 23(3-4):201-5. PubMed ID: 1723683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]